The reported associations between MBL deficiency and poor outcomes in bacterial respiratory disease have raised the possibility that recombinant human MBL replacement therapy in deficient individuals may reduce such complications. The gene discussed is MBL2; the disease is hyperinsulinemic hypoglycemia, familial, 4.